Issues & Trends

Fashion B2B Platform Company Delicious Makes Its KOSDAQ Debut [Listed Today]

Offering Price: 7,000 Won

Kwon Oh Seok
2026-08-12 06:00:08
[Edaily Reporter Kwon Oh Seok ] #Delicious, a K-Fashion B2B (business-to-business) platform company that bridges the wholesale and retail sectors, makes its debut on the KOSDAQ market today (the 12th).
(Photo courtesy of Delicious)

Founded in 2011, Delicious launched the fashion B2B platform “Shinsang Market” in 2013 and has since established itself as Korea’s leading fashion B2B trading platform by digitizing the previously offline-centric wholesale and retail fashion trade. Currently, the company has entered a phase of substantial profit growth centered on high-margin revenue models such as “Shinsang Ad,” “Shinsang Membership,” and “Plus Membership.” It is also accelerating efforts to secure long-term growth drivers by expanding its global new-arrival delivery service and entering the fashion-related SaaS business.
Previously, the company conducted a subscription offering for retail investors over two days on the 3rd and 4th, recording a total subscription ratio of 10.29 to 1. On the 31st of last month, it finalized the final offering price at 7,000 won. The offering amount is 15.4 billion won, with an expected market capitalization of 153 billion won.
Delicious plans to use the funds raised through this offering for △platform enhancement and new service development, △marketing investments for global market expansion, and △entry into the fashion-related SaaS business.
Jeong Chang-han, CEO of DILLI ILLUSTRATE INC., stated, “Following our KOSDAQ listing, we will repay our investors with tangible results through the enhancement of our platform’s revenue model and business expansion.”

Economy

Corporation

IT·Science

Economy

[VC's Pick] From Virtual IP to Space... A Flurry of Interest in Early-Stage Companies

This week (August 31–September 4), startups across various sectors—including virtual intellectual property (IP), freight transportation, social apps, and space technology—secured investments from vent…
2026-09-05 08:01:05

Corporation

SK BIOPHARMACEUTICALS’s $400 Million Gamble… A Bigger Picture Than ‘A Second Excofry’ [Invest Bio]

SK BIOPHARMACEUTICALS(326030)is attributing significance beyond that of a mere follow-up pipeline to Opakalim (BHV-7000), a new epilepsy drug candidate it acquired from the U.S.-based Biohaven. It is …
2026-09-05 06:01:02

IT·Science

GC Wellbeing and JW Pharmaceutical Rally [K-bio Pulse]

South Korea’s pharmaceutical and biotech sector experienced significant volatility on August 13, driven by growth themes in obesity/medical aesthetics, hair loss, and immuno-oncology. #GCWellbeing sur…
2026-09-05 08:02:02